Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hounayda, Bauly"'
Autor:
Markus, Zollinger, Frédéric, Lozac'h, Eunju, Hurh, Corinne, Emotte, Hounayda, Bauly, Piet, Swart
Publikováno v:
Cancer chemotherapy and pharmacology. 74(1)
The absorption, distribution, metabolism, and excretion of the hedgehog pathway inhibitor sonidegib (LDE225) were determined in healthy male subjects.Six subjects received a single oral dose of 800 mg ¹⁴C-sonidegib (74 kBq, 2.0 µCi) under fasting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0e8fbdba2fd427aad7d9116e888feacb
https://pubmed.ncbi.nlm.nih.gov/24817600
https://pubmed.ncbi.nlm.nih.gov/24817600
Autor:
Howard A, Burris, Fabienne, Lebrun, Hope S, Rugo, J Thaddeus, Beck, Martine, Piccart, Patrick, Neven, Jose, Baselga, Katarina, Petrakova, Gabriel N, Hortobagyi, Anna, Komorowski, Edmond, Chouinard, Robyn, Young, Michael, Gnant, Kathleen I, Pritchard, Lee, Bennett, Jean-Francois, Ricci, Hounayda, Bauly, Tetiana, Taran, Tarek, Sahmoud, Shinzaburo, Noguchi
Publikováno v:
Cancer. 119(10)
The randomized, controlled BOLERO-2 (Breast Cancer Trials of Oral Everolimus) trial demonstrated significantly improved progression-free survival with the use of everolimus plus exemestane (EVE + EXE) versus placebo plus exemestane (PBO + EXE) in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::86848947f5c5edb5e957fe0e9e0cad5e
https://pubmed.ncbi.nlm.nih.gov/30934126
https://pubmed.ncbi.nlm.nih.gov/30934126